Venclexta 100 mg: Therapy for CLL/SLL & AML

1
VENCLEXTA (Venetoclax Tablets)

• chronic lymphocytic leukemia

2
Commom Venetoclax Side Effects

• low white blood cell count (neutropenia)
• diarrhea.
• nausea.
• low blood iron (anemia)
• upper respiratory tract infection.
• low levels of platelets in the blood
  (thrombocytopenia)
• fatigue.
• nausea.

3
Venclexta 100 mg is a selective small molecule
BCL2 inhibitor and an oral formulation used alone
or in combination with other medications to treat
certain adult patients with acute myeloid
leukemia (AML) that is newly diagnosed and adult
patients with chronic lymphocytic leukemia (CLL)
or small lymphocytic lymphoma (SLL). This oral
formulation is also being evaluated in the
treatment of certain other sorts of cancer. It
binds to a protein known as BCL2, which exists on
some sorts of cancerous cells. Inhibiting this
protein may help destroy cancerous cells and may
construct them extra sensitive to anticancer
medicines. This BCL2 inhibitor is also called
venetoclax. Patients should avoid consuming
grapefruit juice or grapefruit, Seville oranges
(often used in marmalades), or starfruit during
treatment with Venclexta. These products may be
responsible for increasing the level of Venclexta
in the blood.

• VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA

4
(No Transcript)